- STAT+: Makers of rare disease drugs seek exemption from Trump’s price-cut pilotsA coalition of biotech firms is lobbying to exclude orphan drugs from new federal pilot programs aimed at lowering Medicare drug costs.STAT · 3d ago↗ source
- Recon: Novo sues Lilly over weight-loss drug ads; Gilead, Merck say HIV pill keeps HIV suppressed in two Phase 3 trials<p>Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.</p>raps · 4d ago↗ source
- FDA cites companies for CGMP violations, informed consent failure<p>The US Food and Drug Administration has issued warning letters to several drug makers for failing to meet its current good manufacturing practices (CGMP) requirements and a company for failing t…